The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer

Background: Detection rates of early-stage lung cancer are traditionally low, which contributes to inconsistent treatment responses and high rates of annual cancer deaths. Currently, low-dose computed tomography (LDCT) screening produces a high false discovery rate. This limitation has prompted rese...

Descripción completa

Detalles Bibliográficos
Autores principales: Pohlman, Alexander W., Moudgalya, Hita, Jordano, Lia, Lobato, Gabriela C., Gerard, David, Liptay, Michael J., Seder, Christopher W., Borgia, Jeffrey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858079/
https://www.ncbi.nlm.nih.gov/pubmed/35198099
http://dx.doi.org/10.18632/oncotarget.28202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858079/
https://www.ncbi.nlm.nih.gov/pubmed/35198099
http://dx.doi.org/10.18632/oncotarget.28202

Ejemplares similares